Heron Therapeutics Inc Forecast, price target & analysts
Heron Therapeutics Inc Target price 2025 - Analyst rating & recommendation
Heron Therapeutics Inc Classifications & Recommendation:
Heron Therapeutics Inc Price Target
| Target Price | $6.12 |
| Price | $2.14 |
| Potential |
185.98%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Heron Therapeutics Inc 2026 .
The average Heron Therapeutics Inc target price is $6.12.
This is
185.98%
register free of charge
$9.45
341.59%
register free of charge
$4.04
88.79%
register free of charge
|
|
| A rating was issued by 9 analysts: 8 Analysts recommend Heron Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Heron Therapeutics Inc stock has an average upside potential 2026 of
185.98%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 144.29 | 161.71 |
| 13.58% | 12.07% | |
| Net Margin | -9.41% | -2.24% |
| 89.19% | 76.20% |
6 Analysts have issued a sales forecast Heron Therapeutics Inc 2025 . The average Heron Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
5 Heron Therapeutics Inc Analysts have issued a net profit forecast 2025. The average Heron Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.09 | -0.02 |
| 88.75% | 77.78% | |
| P/E | negative | |
| EV/Sales | 2.63 |
5 Analysts have issued a Heron Therapeutics Inc forecast for earnings per share. The average Heron Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Heron Therapeutics Inc...
Current Heron Therapeutics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 09 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Dec 04 2024 |
| Needham |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| Needham |
Locked
➜
Locked
|
Locked | Sep 25 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 09 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Feb 28 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Dec 04 2024 |
|
Locked
Needham:
Locked
➜
Locked
|
Nov 13 2024 |
|
Locked
Needham:
Locked
➜
Locked
|
Sep 25 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
